RCM
TMDX icon

Regency Capital Management’s Transmedics TMDX Stock Holding History

Regency Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Sell
4,841
-17,005
-78% -$1.44M 0.13% 59
2026
Q1 		$2.17M Buy
+21,846
New +$2.85M 0.97% 33

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Regency Capital Management's TMDX Position: Q2 2026 in Review

Regency Capital Management reduced its Transmedics (TMDX) stake by 78% in Q2 2026, selling an estimated $1.44M and leaving 4,841 shares worth $322K. The position accounts for 0.13% of the portfolio, ranked #59.

Regency Capital Management first reported a position in TMDX in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.17M in Q1 2026. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Regency Capital Management held 4,841 shares of Transmedics worth $322K as of Q2 2026.
  • Regency Capital Management sold 17,005 Transmedics shares in Q2 2026, an estimated $1.44M.
  • Transmedics made up 0.13% of Regency Capital Management's portfolio in Q2 2026, its #59 holding.
  • Regency Capital Management first reported a position in Transmedics in Q1 2026 and has held it in 2 quarters since.
  • Regency Capital Management's Transmedics position peaked at $2.17M in Q1 2026.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Regency Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.